Revolutionizing LMD Treatment: Combined IT & IV Immunotherapy Shows Promise in Melanoma Patients
Researchers at The University of Texas MD Anderson Cancer Center have made significant progress in treating leptomeningeal disease (LMD) caused by metastatic melanoma. LMD is